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Ensheathing glia have been demonstrated to have neuroregenerative properties but this cell type from human
sources has not been extensively studied because tissue samples are not easily obtained, primary cultures
are slow growing, and human cell lines are not available. We previously isolated immortalized ensheathing
glia by gene transfer of BMI1 and telomerase catalytic subunit into primary cultures derived from olfactory
bulbs of an elderly human cadaver donor. These cells escape the replicative senescence characteristic of
primary human cells while conserving antigenic and neuroregenerative properties of ensheathing glia, but
their low proliferative rate in culture complicates their utility as cell models and their application for preclini-
cal cell therapy experiments. In this study we describe the use of a conditional SV40 T antigen (TAg)
transgene to generate human ensheathing glia cell lines, which are easy to maintain due to their robust
growth in culture. Although these fast growing clones exhibited polyploid karyotypes frequently observed
in cells immortalized by TAg, they did not acquire a transformed phenotype, all of them maintaining neuror-
egenerative capacity and antigenic markers typical of ensheathing glia. These markers were also retained
even after elimination of the TAg transgene using Cre/LoxP technology, although the cells died shortly after,
confirming that their survival depended on the presence of the immortalizing genes. We have also demon-
strated here the feasibility of using these human cell lines in animal models by genetically marking the cells
with GFP and implanting them into the injured spinal cord of immunosuppressed rats. Our conditionally
immortalized human ensheathing glia cell lines will thus serve as useful tools for advancing cell therapy
approaches and understanding neuroregenerative mechanisms of this unique cell type.
Key words: Neuroregeneration; Spinal cord injury; Cell therapy; Olfactory ensheathing glia;
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INTRODUCTION and thus culture of bulb-derived glia can only be consid-
ered from cadaver donors. In contrast, mucosa-derived
OEG of volunteers can be cultured from nasal biopsies,Olfactory ensheathing glia (OEG) have been inten-
sively studied in recent years due to their neuroregenera- which can be obtained by outpatient surgery (4,12,26,
37,54).tive properties [(6,17,38,40,48,49,51,61), recently reviewed
by Chiu et al. (9)]. Several groups have demonstrated Like many other differentiated human cells, OEG
have a limited life span in culture (22,31) which dependsaxonal regeneration in murine spinal cord injury models
after ensheathing glia transplantation [(27,29,50), re- on the age of the donor and the culture conditions (20);
eventually the cells enter into a nonreplicative stateviewed in Franssen et al. (19)] and some studies have
even documented functional recovery (24,28,35,39,45, called senescence (25). Many immortalizing strategies
have been described in human cell lines [see Lim et al.46,59) even in humans (5). For future use of this ap-
proach in the clinic it is necessary to characterize OEG (30) for a recent review]. Various studies have reported
that gene transfer of BMI1 and the catalytic subunit ofof human origin: these cells can be obtained either from
the olfactory bulb or from the olfactory mucosa. Surgi- telomerase (TERT) enables the bypass of senescence of
human primary cultures without altering their originalcal intervention of the olfactory bulbs is highly invasive
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properties (11,42). Although we have also found that generative capacity intact. In this study we describe sev-
eral fast growing human ensheathing glia cell lines thatBMI1/TERT transduction can immortalize human OEG
(31), the proliferation rate of these cells is very low, offer the potential as useful tools for studying the neur-
oregenerative properties of this unique glial cell type aslimiting their utility for intensive characterization in
vitro or the development of in vivo assays. well as for testing preclinical cell therapies in vivo in
animal models.Primary culture senescence has been related to the
activation of at least two main pathways: those of
MATERIALS AND METHODSp16Ink4a/Rb and p19Arf/p53 (8). Extensive literature re-
Special Reagentsports the use of SV40 T antigen (TAg) to immortalize
primary cells based upon the ability of this viral protein MTT (3-[4,5-dimethylthiazo-2-yl]-2,5-diphenyltetra-
to bind and inhibit downstream effectors, pRb and p53 zolium bromide), forskolin, DL-2-amino-5-phosphono-
family proteins, of both senescence cascades (1). valeric acid , poly-L-lysine (PLL), and polybrene were
Reversible immortalization is a technique by which purchased from Sigma (St. Louis, Mo). Fetal calf serum
cellular proliferation can be extended by the introduction (FCS) was obtained from Hyclone (Logan, UT). D-
of transgenes [for a recent review, see (30)], and which, MEM/F12 medium, pituitary extract, B-27 supplement,
after the cells have been cultured for the desired time, Neurobasal medium, and colcemid were purchased from
can be silenced or eliminated using temperature-sensi- Gibco (Carlsbad, CA). Primocin was from InvivoGen
tive mutants, ligand-regulated proteins, conditional pro- (San Diego, CA). Lipofectamine Plus reagent was from
moters, or Cre-lox technology . In the latter case, exci- Invitrogen (Carlsbad, CA). Fluoromount G was from
sion of the immortalizing gene is achieved by delivery SouthernBiotech (Birmingham, AL) and papain was
of Cre recombinase, which catalyzes specific recombi- from Worthington’s Papain System (Worthington, Lake-
nation between loxP sites flanking the transgene. Re- wood, NJ). To-Pro-3 was purchased from Molecular
cently, other such cell-reprogramming approaches have Probes (Eugene, OR). Dexamethasone (Fortecortı´n) was
been developed to retrodifferentiate primary tissues into from Merck (Barcelona, Spain); cyclosporin A (Sandim-
induced pluripotent stem (iPS) cells [58), reviewed in mun) from Neoral, Novartis (Barcelona, Spain); keta-
(44)], or even transdifferentiate cells of one tissue type mine from Pfizer, Park-Davis (Madrid, Spain); and
directly into another (16,60,62,63). These strategies of- Domtor and Antisedan from Pfizer, Orion Corporation
fer the possibility to generate any cell type from easily (Espoo, Finland). Tissue-Tek was purchased from Sa-
obtained tissues such as skin fibroblasts, but consider- kura (Zoeterwoude, Netherlands).
able effort in these fields is still needed to achieve di-
Antibodiesrected differentiation of iPS cells into specific cell types.
Reversible immortalization is an approach in which cell Antibodies directed against the listed proteins were
used at the indicated dilutions: amyloid precursor pro-life span can be increased without altering the differenti-
ation stage, thus bypassing the need for directed differ- tein [immunocytochemistry (ICC) 1/200, MAB348], and
nestin (ICC, 1/500, MAB5326), purchased from Chemi-entiation.
We previously used Hlox lentivectors for reversible con International (Temecula, CA); CRE recombinase
[flow cytometry (FC) 1/1000, ab24607], BMI11 (ICCgene transfer of BMI1, TERT, and TAg in a primary
culture of ensheathing glia from a 58-year-old male ca- and FC, 1/200, ab14389), and telomerase (ICC and FC,
1/100, ab32020), obtained from Abcam (Cambridge,daver donor (31). The advanced age of the donor limited
the life span in vitro to a few passages and only the UK); neuroligin 3 (ICC 1/500, sc-1491) and BMI1 (FC,
1/100, H-99 sc-10745) from Santa Cruz BiotechnologyBMI1/TERT combination was able to immortalize these
cells. However their proliferation rate was very slow, (Santa Cruz, CA); CRE recombinase (ICC and FC, 1/
5000, 69050) from Novagen (Gibbstown, NJ); GFP (im-making routine use of these cells difficult. In the present
study we show that although TAg was originally unable munohistochemistry, 1/2000, A11122) from Invitrogen,
Molecular Probes (Eugene, OR); microtubule associatedto immortalize the primary cells of the elderly donor,
delivery of TAg into the BMI1/TERT-transduced slow protein 2 (MAP2) (ICC, 1/400, 514) as previously de-
scribed (53); TAg (FC and ICC, 1/250, 554150) fromgrowing cells strikingly improves their growth charac-
teristics without altering OEG properties such as cell BD Pharmingen (San Diego, CA); phosphorylated neu-
rofilament MAP1B (ICC, 1/500 SMI31) from Stern-type-specific antigenic markers and the capacity to in-
duce axonal regeneration of adult rat retinal ganglion berger M Inc. (Lutherville, MD); S100β (ICC, 1/500, SH-
B1) from Sigma (St. Louis, MO); and vimentin (ICC,neurons. Additionally, because we also used Hlox lenti-
vectors for reversible TAg gene transfer, this transgene 1/200, 814318) from Boehringer (Ingelheim, Germany).
Fluorescent secondary antibodies used for ICC (1/could be efficiently eliminated 1 week after Cre recom-
binase delivery, leaving marker expression and neurore- 1000) and FC (1/500) were: anti-mouse or anti-rabbit
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IgGs labeled with Alexa-488, -555, -647, or -594 (In- (hTL4) was infected with a lentivector encoding TAg at
a MOI of between 2 and 10, generating the cell lines ofvitrogen).
the present study, which preserve the antigenic markers
Lentivector Production and Titration of the original cells. Different clones expressing TAg
were selected and their proliferation rate was calculatedPseudotyped lentivectors were produced by cotrans-
fection of 5 µg of the corresponding lentivector plasmid, as the slope of the line of best fit of the plot of cumula-
tive population doublings (PD) as a function of time (in5 µg of the packaging plasmid pCMVdR8.74 (14), and
2 µg of the plasmid pMD2G (Addgene plasmid 12259 days). We calculated PD = log(Nf/N0)/log 2, where Nf is
the final cell count and N0 is the initial number of cellsencoding vesicular stomatitis virus G envelope protein)
in 10-cm plates of subconfluent 293T cells using Lipo- seeded. Microsoft Excel was used to perform linear re-
gression and calculate the standard error of the slope.fectamine Plus reagent following instructions of the sup-
plier (Invitrogen). Lentivectors expressing immortaliz- Genetic reversion of immortalized human OEG was car-
ried out by infecting the cells with a lentivector encod-ing genes were pLOX-CWBmi1 (Addgene plasmid
12240), pLOX-TERT-iresTK (Addgene plasmid 12245), ing Cre recombinase while a lentivector encoding E-
GFP (LvGFP) was used as a negative control. Deimmor-and pLOX-Ttag-iresTK (Addgene plasmid 12246),
which respectively encode mouse BMI1, TERT coupled talized cells were analyzed for viability using the MTT
assay 120 h after infection as previously described (43).to the HSV-1 thymidine kinase (TK) gene via the en-
cephalomyocarditis virus internal ribosome entry site
(IRES), and TAg coupled to IRES-TK (52). To express Flow Cytometry Analysis
CRE recombinase we used pLOX-CW-CRE (11), a len- Cells were detached by trypsin treatment, fixed by
tivector that transduces cells with a self-excising CRE 10-min incubation in 2% paraformaldehyde (PFA) in
transgene (LvCRE), thus avoiding genotoxicity due to phosphate-buffered saline (PBS), and washed and main-
sustained Cre expression. The pRRLSIN.cPPT.PGK-
tained in PBS at 4°C until analyzed. Immediately priorGFP.WPRE vector (Addgene plasmid 12252), which ex-
to analysis, cells were permeabilized by 2-min treatmentpresses enhanced green fluorescent protein (E-GFP),
with PBS + 0.5% Tween 20, followed by blocking with
was used as a control vector (LvGFP). Lentivectors were PBS + 0.5% Tween 20 + 10% FCS for 15 min. The cells
titered on target cells (hOEG) with serial dilutions of the
then were incubated with the primary antibody diluted
vector supernatants and the number of transduced cells in blocking solution for 20 min. After washing twicedetermined 48 h postinfection by flow cytometry (FAC-
with PBS + 0.5% Tween 20, cells were incubated for 10SCalibur, BD Biosciences, San Diego, CA) using anti-
min with the secondary antibodies. After washing again,bodies directed against the corresponding transgene pro- flow cytometry analysis was performed (FACSCalibur,
tein. BD Biosciences, San Diego, CA). The negative gate was
fixed for each experiment by using the same immunode-Culture, Immortalization, and Deimmortalization
tection conditions with OEG cells that did not expressof Human OEG
the protein of interest (TAg or CRE). The positive frac-The human OEG used in the present study are all
tion for each antigen was determined as the percentagederived from our previous study (31) in which the isola-
of events with higher fluorescence intensity than the
tion and characterization of the glia have been described
negative gate threshold with respect to the total of eventsin detail. Briefly, we used a previously described plotted.
method (41) with modifications (31) to obtain OEG pri-
mary cultures from adult human olfactory bulbs that
Cocultures of Postmitotic Rat Retinal Ganglionwere obtained from the Tissue Bank for Neurological
Neurons With OEGResearch of Madrid. OEG were identified in the olfac-
tory bulb following established morphological and ana- Extension of neurites by postmitotic adult rat retinal
ganglion neurons was used as a model of regenerationtomical guidelines (34) and cultured in ME medium: D-
MEM/F12 (1:1), 10% FCS, 2 mM glutamine, 20 µg/ml in culture (41). Briefly, retinal tissue was extracted from
2-month-old (P60) rats and digested with papain (20 U/pituitary extract, 2 µM forskolin, 50 µg/ml primocin.
Our previous study (31) also describes the infection of ml) in the presence of 50 µM of the NMDA receptor
inhibitor DL-2-amino-5-phosphonovaleric acid. The cellthese human OEG with lentivectors encoding BMI1 and
TERT, isolation of immortalized clones, and the charac- suspension was then plated either on 10 µg/ml poly-L-
lysine (PLL)-treated coverslips or OEG monolayers. Theterization of the clonal lines as well as the primary cells
for the expression of glial antigenic markers including cultures were maintained at 37°C with 5% CO2 in se-
rum-free Neurobasal medium supplemented with B-27S100β, GFAP, neuroligin-3, APP, vimentin, and nestin.
One of these BMI1/TERT-expressing OEG clones 12.5 mM KCl for 96 h before fixing with 4% PFA.
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Quantification of Axon Regeneration (LvCRE) or E-GFP (LvGFP) as control. After 48 h, cells
were trypsinized, counted, and 1,000 cells were seededPreparations were quantified in a blinded manner by
in six-multiwell plates. After 15 days, plates werecounting axons under a 40× objective of an inverted
stained with methylene blue 1% and the number of colo-Axiovert 200 microscope. A minimum of 20 randomly
nies was counted.chosen fields were quantified for each treatment and ex-
periments were performed once (Th1, Tm10, and Ts11) Animal Treatment
or six times (poly-L-lysine, hTL4, and Ts14). Axonal
All animal experimentation was carried out in animalregeneration was quantified as the percentage of neurons
facilities (Institutional Registration No. 28079-19A, Span-with an axon, whereas total neuron number was deter-
ish Ministry of Agriculture) complying with the Spanishmined by staining with the microtubule-associated pro-
Royal Decree 223/1988, which follows the Europeantein (MAP) 2 antibody. Axons were defined as polarized
Council Directive 86/609/EEC (1986), and approved byneurites stained with antibodies against phosphorylated
national and institutional bioethics committees.MAP1B and the high molecular weight neurofilament
To study tumorigenicity of Ts14 cells, six 12-week-subunit proteins. We also determined the axonal regen-
old Hsd:Athymic Nude-Foxn1nu mice (Harlan Interfaunaeration index, a parameter defined as the axonal length/
Iberica, Barcelona, Spain) were subcutaneously inocu-field as well as the percentage of neurons that regenerate
lated with 106 cells in the flanks. As positive controls,their axons. Quantitative image analysis was performed
six similar inoculations were performed using U-87 MGusing the NeuronJ plugin (E. Meijering) of the ImageJ
glioblastoma cell line [ATTC number HTB-14, (3)]program (Wayne Rasband, National Institutes of Health,
while two animals were left untreated as negative con-USA).
trols. The development of tumors was followed up for
at least 6 weeks.Karyotype Analysis
To study the survival of Ts14 cell xenografts, maleChromosomal studies were performed at the Genetics
2-month-old Wistar rats weighing approximately 250 gDepartment of the Hospital “La Paz” in Madrid. Meta-
were treated with dexamethasone (from 2 weeks beforephase spreads were prepared from cells treated with 100
cell therapy until euthanasia, 2 mg/L in drinking water,ng/ml colcemid for 6 h and analyzed by standard proto-
estimated as 30 ml/day) or cyclosporine A (15 mg/kg/cols for high-resolution GTL banding (55).
day intraperitoneally from 3 days before cell therapy) or
Anchorage Independent Growth dexamethasone (in the same conditions) combined with
cyclosporine A (15 mg/kg/day in drinking water from 3Cells were seeded in 12-multiwell plates at 104 cells/
days before cell therapy), n = 3 per treatment group.well in 0.35% agar in DMEM culture medium over a
Rats were operated on under anesthesia (intraperitoneal0.7% agar layer. Plates were incubated for 23 days, after
injection 80 mg/kg ketamine and 0.32 ml/kg Domtor) towhich time colonies were large enough to be visualized
produce a bilateral lesion in the dorsal columns at spinalby staining with MTT (200 µg/ml) for 6 h and photo-
level C3 using watchmaker’s forceps (7). To transplantgraphed using a flatbed scanner. Soft agar assays were
Ts14-GFP cells, a total of 1.5 × 105 cells (1 × 104 cells/performed in triplicate.
µl) were injected with a Hamilton syringe coupled to a
Immunocytochemistry glass micropipette, into the dorsal half of the spinal cord
(depth 2 mm) at three rostrocaudal levels: at the lesionCells were grown on sterile glass coverslips and fixed
with 4% PFA in PBS. After blocking with PBS contain-
ing 1% FCS, 0.1% Triton X-100 for 30 min, and an
Table 1. Proliferation Rate of Each Population
extra permeabilization of 10 min in PBS containing
0.1% SDS for nuclear antigens, cells were washed with PD/Day SE
PBS and stained by indirect immunofluorescence using
Control 0.1761 4.6 × 10−7the antibodies described above. Samples were mounted
BMI TERT 0.2284 0.0129in Fluoromount G and were observed in an Axiovert 200
Th1 0.6360 0.0062(Zeiss, Oberkochen, Germany) fluorescence microscope
Tm10 0.5106 0.0120
or in a Radiance 2000 confocal system (Bio-Rad, Her-
Ts11 0.4253 0.0187
cules, CA) coupled to an Axiovert S100 TV inverted Ts14 0.4276 0.0070
microscope (Zeiss).
Values represent the slope of the line of best fit of the plot of cumula-
tive population doubling (PD) as a function of the time in days, PDs =Colony Formation Assay
log (Nf/N0)/log 2, where Nf is the final cell count and N0 is the initialTs14 cells were infected at different MOI (0, 1, 2.5, number of cells seeded. The standard error of the proliferation rate
(slope of the line of best fit) is shown.and 10) with lentivectors encoding Cre recombinase
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site and 1 mm caudal to and rostral to the lesion (5 µl/
min/site; a total of 15 µl). Rats were reanimated by in-
traperitoneal injection of 80 ml/kg of Antisedan. After
the indicated times rats were sacrificed and tissues were
fixed by transcardial perfusion. The spinal cords were
dissected out of these animals and embedded in Tissue-
Tek and quick frozen in dry ice. Serial cryostat sagittal
sections (20 µm) were prepared, immunohistochemistry
for E-GFP was performed (using the above described
immunocytochemistry protocol), and sections were ob-
served under an Axiovert 200 (Zeiss, Oberkochen, Ger-
many) fluorescence microscope.
Statistical Analysis
Analysis of variance (ANOVA) was performed to
test the differences between experimental factors and
their interaction. If the differences were significant,
Bonferroni’s post hoc test for multiple comparisons be-
tween means was carried out.
RESULTS
Increased Proliferation of hTL4 by TAg Addition
In our previous study (31) using primary cultures de-
rived from human olfactory bulbs of a 58-year-old donor
we were unable to obtain immortalized OEG using lenti-
vectors expressing TAg either alone or in combination
with TERT, but, curiously, we did obtain OEG immor-
talized by BMI1 and TERT. These cells could be cloned
and expanded for at least 20 duplications, permitting our
characterization of their antigenic profile as well as their
neuroregenerative properties in culture assays (31), but
their slow growth rate (duplication time of approxi-
mately 10 days), compromises their ease of use as cell
FACING COLUMN
Figure 1. Effect of SV40 T antigen on human olfactory en-
sheathing glia cell lines. Human OEG immortalized originally
by BMI1 and TERT (BMI1/TERT) were subsequently in-
fected with a lentivector encoding SV40 T antigen. (A) Analy-
sis of T antigen expression by flow cytometry of four different
clones of BMI1/TERT-immortalized cells transduced by TAg
(Th1, Tm10, Ts11, and Ts14). Graphs show means and SDs
of fluorescence intensity. (B) Representative phase contrast
image of BMI/TERT-immortalized hOEG and (C) one TAg-
expressing clone Ts14. Scale bars: 100 µm. (D, E) Neurore-
generative capacity of TAg-accelerated OEG cell lines com-
pared with the BMI1/TERT-immortalized parental clone in co-
culture assays with adult rat retinal ganglion neurons.
Neuroregeneration was scored by determining the percentage
of neurons extending axons (D) as well as by measuring a
parameter proportional to the average length of regenerated
axons (E). The graphs show means and SDs of six independent
experiments with poly-L-lysine (PLL), BMI TERT, and Ts14;
the rest of the clones were measured once. ***p < 0.001
(ANOVA and post hoc Bonferroni test, with respect to PLL).
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Figure 2. Karyotype analysis and anchorage-independent growth of human olfactory ensheathing
glia cells. (A) Representative high-resolution GTL-banded metaphase spreads prepared from pri-
mary hOEG (control) and those immortalized by BMI1/TERT or BM1/TERT/TAg (Ts14 clone).
Quantitative data are given in Table 2. Arrows indicate gross deletions and A, aberrant chromo-
somes. (B) Representative images of anchorage-independent growth in soft agar of these cells
using the human glioblastoma cell line U-87 MG as a positive control.
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Table 2. Karyotype Analysis
No. Metaph.
Transgenes Result Details Analyzed
Control diploid 46, XY male 11
Bmi hTERT (hTL4) hypodiploid missing Y 15 hypodiploid, 45, missing Y; one additionally missing 21; 17
one additionally missing 21 or 22
Bmi hTERT TAg (Ts14) polyploid 25 hypertriploid, 72–80, varying chromosome involvement. 25
All displayed multiple rearrangements. No diploid cells
observed
models or for developing therapeutic approaches in ani- ative capacity of Ts14 cells compared to that of the
parental line hTL4 as well as that of the original primarymal models.
We thus explored the ability of a lentivector encoding OEG cells (31).
To test the transforming potential of these immortal-SV40 large T antigen (TAg) to increase the proliferative
rate of these BMI1/TERT-immortalized OEG. We ini- ized cells we studied their capacity for anchorage-inde-
pendent growth. None of these cells was able to formtially analyzed four clones selected according to their
different replication rates (Table 1): Th1 with a high rep- colonies in soft agar (Fig. 2B) in the same conditions as
our human glioblastoma-positive control cell line U-87lication rate, Tm10 with an intermediate replication rate,
and Ts11 and Ts14 with slower replication rates. The MG. It thus appears that in spite of substantial karyo-
typic abnormalities, Ts14 cells do not exhibit tumori-mean TAg expression level of each clone, as quantified
by flow cytometry (Fig. 1A), did not appear to correlate genic behavior. Additionally, six immunodeficient nude
mice were inoculated with Ts14 cells in the flanks andwith proliferative rate (compare with Table 1). Trans-
duction by TAg provoked a significant morphological none of them have developed tumors at least during the
first 6 weeks of an ongoing experiment. In contrast, sixchange: whereas human OEG transduced by BMI1/
TERT are large and flattened cells (Fig. 1B), TAg ex- out of six inoculations using the human glioblastoma
cell line U-87 MG developed noticeable tumors in thepressing clones are smaller, fibroblast-like, and divide
until reaching confluence (Fig. 1C). first week.
We next evaluated if TAg expression alters OEG re-
Deimmortalization of Ts14generative properties, by comparing the capacity of the
four TAg-transduced cell lines to induce axonal regener- Because all of the immortalizing genes transduced in
our OEG cell lines were flanked by loxP sites (52), theyation in adult rat retinal ganglion neurons (41), with that
of the parental BMI1/TERT-immortalized line (hTL4). could be excised by Cre recombinase delivery to the
cells. To achieve this “deimmortalization,” we used aThe percentage of neurons with an axon (Fig. 1D) was
similar in one of the clones (Ts14) and slightly de- self-excising Cre lentivector (11), thus avoiding long-
term Cre recombinase expression, which may have det-creased in the other three (Th1, Tm10, Ts11). Indeed, in
the case of Ts14 the axonal regeneration index was rimental genotoxic effects (36,56). As shown in Figure
3A, TAg expression could be eliminated from a popula-slightly higher and we thus chose this clone for more
detailed studies (Fig. 1E). tion of TAg-transduced hTL4 cells by infection with a
Cre-encoding lentivector, whereas infection with a con-
Karyotype Stability and Transforming Potential trol (GFP-expressing) lentivector under the same condi-
tions had no effect on TAg expression. Immunocyto-To study genomic stability after OEG transduction, a
high resolution GTL banding assay was performed (Fig. chemical analysis of Ts14 cells confirmed the nuclear
localization of BMI1, TERT and TAg, and elimination2A, Table 2). Untransduced OEG showed a normal male
diploid karyotype without any alteration in all meta- of their expression with the appearance of Cre in the
nucleus (Fig. 3B). Flow cytometry analysis showed TAgphases analyzed. Some chromosomal instability was evi-
dent after BMI/TERT immortalization: all hTL4 cells expression was eliminated from Ts14 cells positive for
Cre, but not GFP (Fig. 3C) and that the percentage oflacked the Y chromosome and two of the metaphases
analyzed showed the additional absence of chromosome cells that lost TAg expression was proportional to the
dosage of LvCre lentivector but unaffected by LvGFP21 or 22. TAg transformation markedly increased chro-
mosome instability: all Ts14 cells were polyploid with lentivector (Fig. 3D). Some of the cells that are Cre neg-
ative also show loss of TAg, due to the self-excisingvarying numbers of chromosomes and multiple re-
arrangements. Interestingly, these gross karyotypic alter- property of the Cre-encoding vector (Fig. 3C).
Having confirmed that Cre expression in Ts14 cellsations seem to have minimal effect on the neuroregener-
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Figure 3. Cre recombinase-mediated excision of TAg from immortalized human olfactory ensheathing glia. (A) Kinetics of elimina-
tion of TAg expression. TAg-transduced OEG originally immortalized by BMI1/TERT were not infected (uninf) or infected with
a lentivector encoding CRE (LvCRE) or a control lentivector carrying E-GFP (LvGFP) at a MOI of 10 and at the indicated times.
TAg expression was monitored by flow cytometry. (B) Representative immunofluorescence images showing BMI1, TERT, TAg,
and CRE expression in Ts14 cells before and after deimmortalization with LvCRE (MOI: 1–10). Scale bars: 20 µm. (C) Flow
cytometry dot plots representing TAg expression on the x-axis and Cre recombinase or GFP expression on the y-axis. Ts14 cells
not treated with vectors (control) or infected with lentivectors enconding Cre recombinase (LvCRE, right column) or E-GFP
(LvGFP, left column) at the indicated MOI. (D) Graphs showing quantification of the experiment detailed in (C). Cells positive
for TAg expression: right gates; cells positive for CRE or GFP: upper gates.
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eliminates expression of the transgenes, thus genetically days after infection) was drastically reduced by treat-
ment with LvCre vector (Fig. 4A) in a dose-dependentreverting these immortalized human OEG cells, we next
characterized the biological effect of this “deimmortali- manner (Fig. 4B). The effect of deimmortalization on
the long-term survival of Ts14 cells was also studied byzation.” Strikingly, while treatment with LvGFP vector
did not significantly affect the cells, viability (assayed 5 plating the cells at high dilution and observing colony
Figure 4. Cell death of Ts14 cells after deimmortalization by Cre-mediated transgene excision.
(A, B) Viability of Ts14 cells was measured by the MTT assay 120 h after infection with lentivec-
tors. Cell viability is expressed as a percentage of uninfected cell (control) values and the graphs
display the means and SDs of three independent samples. ***p < 0.001 (ANOVA and post hoc
Bonferroni test). (A) Cell viability was severely compromised by infection with LvCRE vector
while an equal amount of LvGFP vector had no significant effect. (B) Infection with LvCRE at
the indicated various MOI showed a dose-dependent effect on cell viability. (C) Representative
images of the colony formation assay of Ts14 cells infected with LvGFP or LvCRE lentivectors
at the indicated various MOI. (D) Quantification of colony number in the assay shown in (C). The
graph depicts the means and SDs of three different samples. ***p < 0.001 (ANOVA and post hoc
Bonferroni test).
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formation after 15 days (Fig. 4C, D). Again, the survival
of Ts14 cells was reduced in a dose-dependent manner
by the LvCre vector but not by the LvGFP vector, al-
though a slight toxic effect (probably due to the lentivec-
tor itself) was observed in this assay (Fig. 4D; compare
LvGFP open bars with control gray bar). Our results
thus indicate that Ts14 proliferation depends on the
presence of the immortalizing transgenes and the cessa-
tion of cell division when these are removed provokes
cell death.
Using immunofluorescence we also characterized
Ts14 cells for the expression of typical OEG markers
(Fig. 5) as well as the effect of deimmortalization on these
markers. Similarly to primary human OEG, Ts14 cells
stained positively for S100β, APP, neuroligin 3, nestin,
and vimentin both before and after infection by the LvCre
vector, showing that neither TAg transduction nor trans-
gene elimination modified the OEG antigenic profile of
these cells compared with the parental cell line (31).
Xenografts of Ts14 for In Vivo Evaluation of Human
OEG Cell Therapy
The development of human cell-based therapies is
fraught with practical problems such as the lack of large
amounts of homogenous, precharacterized graft tissue,
and viable in vivo models in which to perform preclini-
cal trials. Our human OEG cell lines offer one way to
obtain enough graft material of known characteristics,
so we next investigated the possibility of using these
cells as xenografts in a rat model of spinal cord lesion
(39). To trace these cells in vivo we labeled the Ts14
cell line by infecting them with a lentivector expressing
E-GFP (LvGFP, MOI: 10) and selecting a clone
(Ts14G) expressing easily detectable levels of GFP by
flow cytometry. These cells were transplanted into rat
spinal cords subjected to dorsal column crush at C3
level. Although transplanted Ts14G cells could be
clearly visualized 24 h after transplantation (Fig. 6A),
none could be detected 1 week after inoculation, proba-
bly due to a xenograft-induced immune response (Fig.
6B). To test this hypothesis we studied the effect of im-
munosuppressive treatments: animals were treated with
dexamethasone from 2 weeks before transplantation
and/or cyclosporine A until the day of sacrifice. Using
any of these three immunosuppressive protocols, Ts14G
cells could be clearly visualized 1 week after transplan- Figure 5. Immunocytochemical analysis of Ts14 cells. Repre-
sentative images of immunofluorescence staining for charac-tation (Fig. 6C–E) and in some cases positive cells
teristic OEG markers in Ts14 cells before and after deimmor-could even be detected 4 weeks after transplantation
talization by LvCRE infection (MOI: 10). Similar to primary(Fig. 6F). These results encouragingly indicate that these human OEG (31), Ts14 cells exhibited immunostaining for the
human OEG cell lines can be used for in vivo studies in markers S100β, APP, neuroligin-3, nestin, and vimentin, and
rodents, even when transplanted into an immunologi- expression of these markers was not altered by deimmortaliza-
tion. Scale bar: 20 µm.cally hostile environment such as the crush-lesioned spi-
nal cord. Further experiments using immunodeficient
animals may extend the survival of these cells to enable
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Figure 6. Effect of immunosuppression on persistence of human Ts14 cells transplanted into a rat
model of spinal cord lesion. After dorsal column crush at the level of C3 in Wistar rats, Ts14G
cells (1.5 × 105 cells distributed equally in three injections) were innoculated into the lesion site.
Three animals were used for each treatment. Representative images shown are of GFP immunoflu-
orescence staining of spinal cord saggital sections. Untreated rats 24 h (A) and 1 week (B) after
transplantation. Immunosuppressed rats 1 week after transplantation treated with dexamethasone
(C), cyclosporine A (D), or both (E), or 4 weeks after transplantation treated with cyclosporine A
(F). Scale bars: 200 µm (A) or 500 µm (B–F).
important long-term functional studies of human OEG- Although different combinations of immortalizing
genes, such as BMI1 and TERT (31), are able to immor-mediated neuroregeneration in vivo.
talize OEG cells, the proliferation rates are low, making
very difficult their characterization and use in animalDISCUSSION
experiments. In this work we have demonstrated that
TAg efficiently increases proliferation rate of these pre-The generation of neural cell lines from human pri-
mary cultures greatly facilitates the characterization of viously immortalized cells while maintaining their lin-
eage specific markers and neuroregenerative properties.these cells as well as their development for use for cell-
based therapies. Depending on cell type, culture condi- Immortalization can be considered as the bypass of
senescence, which is the consequence of cell aging intions and donor age primary cultures have varying repli-
cative life spans, after which they enter a nonreplicative culture conditions. Two main pathways are involved in
this process: those of p16/pRB and p19/p53/p21 (8).state called senescence (25). Immortalization offers the
possibility to increase the life span of cells, thus en- Successful bypass of senescence depends on the ability
of the immortalizing genes to repress both pathwaysabling the amplification of scarce primary neural tissue.
The production of immortalized stocks also assures a (13) as well as the preexisting cellular levels of the pro-
teins involved in these pathways (2). Indeed, we pre-homogeneous source of cells which can be precharacter-
ized to generate models to enable the comparative re- viously demonstrated that OEG from an elderly donor
could be immortalized by the BMI/TERT combinationsearch that is necessary for a cell therapy product.
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but not by using TAg either alone or combined with using reversibly immortalized cells such as Ts14, which
offer the possibility to efficiently obtain expanded pri-TERT (31), probably because TAg is unable to block
senescence progression in this cell type (22). However, mary tissues without altering the desired properties of
the cells.our present study indicates that once the senescence pro-
cess is inhibited by the BMI1/TERT combination, TAg
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